期刊文献+
共找到171篇文章
< 1 2 9 >
每页显示 20 50 100
Parosteal Lipoma of Femur—A Case Report
1
作者 Yogesh S. Salphale Prakash Lalwani +2 位作者 Wasudeo M. Gadegone Ajay Mehra Ravi Alurwar 《Surgical Science》 2015年第12期549-554,共6页
A case of 16 yrs male patient with parosteal lipoma affecting the lower metaphyseal end of the left femur is presented. Clinical suspicion, plain radiographs, CT (Plain and 3 D) as well as MRI suggested a diagnosis of... A case of 16 yrs male patient with parosteal lipoma affecting the lower metaphyseal end of the left femur is presented. Clinical suspicion, plain radiographs, CT (Plain and 3 D) as well as MRI suggested a diagnosis of parosteal lipoma. Lipomas may be defined as benign lesions of mature adipose tissue without evidence of cellular atypia [1]. Lipomas are the most common soft tissue lesions and surprisingly are among the rarest bone neoplasias. The most frequent complaints are a tumoral convexity presenting as a visible or palpable mass or a mild-intensity, dull pain. The parosteal type is a rare tumor accounting for 0.3% of all lipomas [2] and is usually asymptomatic. It is seen commonly affecting adults aged over 40 [3]. The present article describes a rare case of parosteal lipoma located in the femur, with extensive hyperostosis visible on plain xray and confirmed by imaging studies (CT and MRI). Unlike the parosteal lipomas reported in adults over 40 yrs in this case it presented in a much younger age group. 展开更多
关键词 Parosteal LIPOMA Nonpulsatile mass tumoral mass
下载PDF
补中益气汤治疗恶性肿瘤疾病的临床及基础研究进展 被引量:19
2
作者 钱佳南 孙博云 胡鸿毅 《河北中医药学报》 2021年第5期59-64,共6页
补中益气汤为著名医家李东垣所创制的传统名方,已被广泛应用于临床,在治疗恶性肿瘤相关疾病中疗效卓著。近年来有关补中益气汤治疗恶性肿瘤疾病的临床实践及机制研究日益深入,涉及名医经验、理论剖析、药理机制等多个研究方面,为此,结... 补中益气汤为著名医家李东垣所创制的传统名方,已被广泛应用于临床,在治疗恶性肿瘤相关疾病中疗效卓著。近年来有关补中益气汤治疗恶性肿瘤疾病的临床实践及机制研究日益深入,涉及名医经验、理论剖析、药理机制等多个研究方面,为此,结合近年来国内外文献论述对补中益气汤治疗恶性肿瘤疾病的临床及基础研究进展做一综述。 展开更多
关键词 补中益气汤 恶性肿瘤 药毒 癥瘕 术后化疗 提高免疫 研究进展
下载PDF
Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: A systematic review and meta analysis 被引量:16
3
作者 Srinivas R Puli Nikhil Kalva +8 位作者 Matthew L Bechtold Smitha R Pamulaparthy Micheal D Cashman Norman C Estes Richard H Pearl Fritz-Henry Volmar Sonu Dillon Michael F Shekleton David Forcione 《World Journal of Gastroenterology》 SCIE CAS 2013年第23期3678-3684,共7页
AIM: To detect pancreatic neuroendocrine tumors (PNETs) has been varied. This study is undertaken to evaluate the accuracy of endoscopic ultrasound (EUS) in detecting PNETs.METHODS: Only EUS studies confirmed by surge... AIM: To detect pancreatic neuroendocrine tumors (PNETs) has been varied. This study is undertaken to evaluate the accuracy of endoscopic ultrasound (EUS) in detecting PNETs.METHODS: Only EUS studies confirmed by surgery or appropriate follow-up were selected. Articles were searched in Medline, Ovid journals, Medline nonindexed citations, and Cochrane Central Register of Controlled Trials and Database of Systematic Reviews. Pooling was conducted by both fixed and random effects model). RESULTS: Initial search identified 2610 reference articles, of these 140 relevant articles were selected and reviewed. Data was extracted from 13 studies (n = 456) which met the inclusion criteria. Pooled sensitivity of EUS in detecting a PNETs was 87.2% (95%CI: 82.2-91.2). EUS had a pooled specificity of 98.0% (95%CI: 94.3-99.6). The positive likelihood ratio of EUS was 11.1 (95%CI: 5.34-22.8) and negative likelihood ratio was 0.17 (95%CI: 0.13-0.24). The diagnostic odds ratio, the odds of having anatomic PNETs in positive as compared to negative EUS studies was 94.7 (95%CI: 37.9-236.1). Begg-Mazumdar bias indicator for publication bias gave a Kendall's tau value of 0.31 (P = 0.16), indication no publication bias. The P for χ2 heterogeneity for all the pooled accuracy estimates was > 0.10. CONCLUSION: EUS has excellent sensitivity and specificity to detect PNETs. EUS should be strongly considered for evaluation of PNETs. 展开更多
关键词 Endoscopic ULTRASOUND ULTRASOUND ENDOSONOGRAPHY Pancreatic mass NEUROENDOCRINE tumors Sensitivity SPECIFICITY Positive PREDICTIVE VALUE Negative PREDICTIVE VALUE
下载PDF
测定胃癌患者肿瘤组织与外周血中前列腺素E_2的临床意义 被引量:15
4
作者 俞慧宏 吴小翎 +1 位作者 张苜 宁波 《第三军医大学学报》 CAS CSCD 北大核心 2008年第5期444-446,共3页
目的测定胃癌患者肿瘤组织及外周血中前列腺素E2(prostaglandin E2,PGE2)含量。方法用PGE2酶联免疫试剂盒分别测定40例胃癌患者肿瘤组织、癌旁切缘组织及术前外周血中PGE2含量。结果胃癌组织的PGE2含量明显高于癌旁切缘组织,分别为(8.22... 目的测定胃癌患者肿瘤组织及外周血中前列腺素E2(prostaglandin E2,PGE2)含量。方法用PGE2酶联免疫试剂盒分别测定40例胃癌患者肿瘤组织、癌旁切缘组织及术前外周血中PGE2含量。结果胃癌组织的PGE2含量明显高于癌旁切缘组织,分别为(8.225±2.425)、(1.669±0.287)ng/g,两者差异有统计学意义(P<0.01),低分化和高中分化胃癌组织PGE2含量分别为(9.02±2.28)、(5.38±0.35)ng/g,两者有显著性差异(P<0.05)。外周血中PGE2含量与胃癌组织PGE2含量呈正相关(r=0.889,P<0.01)。肿瘤直径≥5cm和<5cm的胃癌患者外周血中PGE2含量差异有统计学意义(P<0.05)。低分化和高中分化胃癌患者外周血中PGE2含量差异也有统计学意义(P<0.05)。胃癌组织及外周血中PGE2含量与患者年龄、性别无关,与肿瘤部位、浸润深度、临床病理分期及是否淋巴结转移也无关。结论胃癌患者肿瘤组织中PGE2含量增高,其外周血PGE2含量也随之增高,表明外周血PGE2水平与胃癌组织释放的PGE2含量成正比。测定外周血中PGE2可以间接评估胃癌患者的肿瘤大小与分化程度。 展开更多
关键词 胃癌 前列腺素E2 肿瘤组织 外周血
下载PDF
CDHS 801在光动力学治疗膀胱癌中的有效性和安全性研究 被引量:11
5
作者 方杰 方祖军 张元芳 《上海医学》 CAS CSCD 北大核心 2003年第5期306-308,共3页
目的 验证新型光敏剂CDHS 80 1的临床有效性和安全性。方法  5 4例膀胱癌患者随机分为试验组 ( 2 7例 )和对照组 ( 2 7例 )。病理为T1 、T2 期。治疗组口服CDHS 80 1( 4mg/kg) 2 4h后进行光动力学治疗(PDT) ,能量密度为 5 0J/cm2 ;治... 目的 验证新型光敏剂CDHS 80 1的临床有效性和安全性。方法  5 4例膀胱癌患者随机分为试验组 ( 2 7例 )和对照组 ( 2 7例 )。病理为T1 、T2 期。治疗组口服CDHS 80 1( 4mg/kg) 2 4h后进行光动力学治疗(PDT) ,能量密度为 5 0J/cm2 ;治疗期间不避光 ;72h后行经尿道膀胱肿瘤电切术 (TURBT)取标本。对照组不服药 ,行TURBT治疗。所有患者随访 6~ 12个月。结果 治疗组的肿瘤坏死发生率和面积均明显高于对照组(P <0 .0 5 ) ;样本的平均DNA质量 ,治疗组的均数低于对照组 (P <0 .0 5 )。治疗后肿瘤巨体发生明显改变 :轮廓增大呈水泡样疏松的结构 ,并有成片坏死灶和“卫星灶”出现。治疗组未出现光敏性皮炎或肝、肾功能异常。结论 CDHS 80 1治疗T1 、T2 期膀胱癌 ,该PDT方法是有效的。 展开更多
关键词 膀胱癌 新型光敏剂 CDHS801 光动力学疗法 治疗 有效性 安全性
下载PDF
张锡纯治疗肿瘤学术思想浅析 被引量:10
6
作者 陈赐慧 花宝金 《浙江中医药大学学报》 CAS 2014年第6期707-710,共4页
[目的]探析张锡纯治疗肿瘤的学术思想。[方法]通过对张锡纯《医学衷中参西录》中相关文献的探究,总结张锡纯对于肿瘤的认识及治疗肿瘤的学术思想。[结果]张锡纯对噎膈、反胃、癥瘕等肿瘤相关疾病的症候有独特的认识,认为此类疾病以气虚... [目的]探析张锡纯治疗肿瘤的学术思想。[方法]通过对张锡纯《医学衷中参西录》中相关文献的探究,总结张锡纯对于肿瘤的认识及治疗肿瘤的学术思想。[结果]张锡纯对噎膈、反胃、癥瘕等肿瘤相关疾病的症候有独特的认识,认为此类疾病以气虚、血瘀、瘤赘为主要病因,治疗上主张中西医结合,补破并用,特别强调顾护人体的正气和脾胃功能的强弱。处方用药以益气活血为主,创制参赭培气汤、理冲汤等专方,同时善用三棱、莪术、水蛭、鸡内金等专药。[结论]张锡纯治疗肿瘤主张中西医结合,特别强调人体正气的作用,善用益气活血治法,对于后世医家进行疾病的诊疗施治具有重要的指导意义。 展开更多
关键词 张锡纯 肿瘤 学术思想 噎膈 反胃 癥瘕
下载PDF
Purification and Characterization of Flammulin,a Basic Protein with Anti-tumor Activities from Flammulina velutipes 被引量:10
7
作者 陈畅 薛久刚 +3 位作者 周凯松 李彦 张晗星 张长铠 《Journal of Chinese Pharmaceutical Sciences》 CAS 2003年第2期60-65,共6页
Aim To purify and characterize flammulin, a basic protein with anti-tumoractivities. Methods Ammonium sulfate, ethanol fractionation and column chromatography were used forseparation and purification. Electrophoretic ... Aim To purify and characterize flammulin, a basic protein with anti-tumoractivities. Methods Ammonium sulfate, ethanol fractionation and column chromatography were used forseparation and purification. Electrophoretic analysis, amino acid analysis, and MS of flammulin werecarried out. Results Flammulin was purified to electrophoretic homogeneity and crystallized. With amolecular mass of 19891.13 Da, pI 8.9, λ_(max) = 276 - 278 nm, λ_(min) = 250 nm, flammulin wascharacterized by its lack of methionine. Fingerprint mapping of flammulin was determined by MALDI-MSfollowing in-gel protease digestion; no close matches were identified. Conclusion Flammulin waspurified to electrophoretic homogeneity, and its characteristics are discussed for the first time. 展开更多
关键词 anti-tumor activities flammulin flammulina velutipes PURIFICATION CHARACTERIZATION mass spectrometry
下载PDF
代谢组学在结直肠癌肿瘤标志物发现中的研究进展 被引量:9
8
作者 杨阳 王志鹏 +4 位作者 高守红 张凤 李明明 仲人前 陈万生 《药物分析杂志》 CAS CSCD 北大核心 2018年第6期915-926,共12页
代谢组学用于各种癌症的早期诊断和个性化治疗,具有巨大潜力。科研工作者主要运用色谱-质谱联用、毛细管电泳-质谱以及核磁共振等代谢组学技术,在结直肠癌患者的细胞或组织匀浆液、血液、体液以及排泄物中发现小分子内源性代谢物的变化... 代谢组学用于各种癌症的早期诊断和个性化治疗,具有巨大潜力。科研工作者主要运用色谱-质谱联用、毛细管电泳-质谱以及核磁共振等代谢组学技术,在结直肠癌患者的细胞或组织匀浆液、血液、体液以及排泄物中发现小分子内源性代谢物的变化及变化规律,其中一些代谢物可能成为结直肠癌早期诊断、严重程度评估、过程预测等的肿瘤标志物。本文综述了基于代谢组学进行结直肠癌肿瘤标志物研究的进展,为结直肠癌肿瘤标志物进一步的寻找、发现、确证及临床应用提供参考。 展开更多
关键词 结直肠癌 肿瘤标志物 代谢组学 研究技术 色谱 毛细管电泳 质谱 核磁共振
原文传递
Evaluation of internal and shell stiffness in the differential diagnosis of breast non-mass lesions by shear wave elastography 被引量:8
9
作者 Ping Xu Mei Wu +3 位作者 Min Yang Juan Xiao Zheng-Min Ruan Lan-Ying Wu 《World Journal of Clinical Cases》 SCIE 2020年第12期2510-2519,共10页
BACKGROUND The diagnostic specificity of conventional ultrasound for breast non-mass lesions(NMLs)is low at approximately 21%-43%.Shear wave elastography(SWE)can distinguish benign from malignant lesions by evaluating... BACKGROUND The diagnostic specificity of conventional ultrasound for breast non-mass lesions(NMLs)is low at approximately 21%-43%.Shear wave elastography(SWE)can distinguish benign from malignant lesions by evaluating the internal and peripheral stiffness.SWE has good reproducibility and high diagnostic efficacy.However,there are very few independent studies on the diagnostic value of SWE in breast NMLs.AIM To determine the value of SWE in the differential diagnosis of breast NMLs.METHODS This study enrolled a total of 118 patients with breast NMLs who underwent SWE examinations in the Beijing Shijitan Hospital Affiliated to Capital Medical University and The Second Hospital of Shandong University from January 2019 to January 2020.The internal elastic parameters of the lesions were recorded,including maximum(Emax),mean(Emean)and minimum elastic values and the standard deviation.The following peripheral parameters were noted:Presence of a“stiff rim”sign;Emax,and Emean elasticity values within 1 mm,1.5 mm,2 mm,2.5 mm and 3 mm from the edge of NMLs.The receiver operating characteristic curve of each parameter was drawn,and the areas under the curve were calculated.RESULTS Emax,Emean and elastic values,and the standard deviation of the internal elastic values in malignant NMLs were significantly higher than those in benign NMLs(P<0.05).The percentage with the“stiff rim”sign in malignant NMLs was significantly higher than that in the benign group(P<0.05),and Emax and Emean at the shell of 1 mm,1.5 mm,2 mm,2.5 mm and 3 mm in the malignant group were all higher than those in the benign group(P<0.05).Of the surrounding elasticity values,Emax of the shell at 2.5 mm in malignant NMLs had maximum areas under the curve of 0.900,and the corresponding sensitivity and specificity were 94.57%and 85.86%,respectively.CONCLUSION The“stiff rim”sign and multiple quantitative elastic values within and around the lesion had good diagnostic performance in the differential diagnosis of breast NMLs.Emax in peripheral tissue ha 展开更多
关键词 Breast tumor Shear wave elastography Non-mass lesions Stiff rim sign Ultrasound Diagnosis
下载PDF
小金丹治疗肿瘤研究探讨 被引量:5
10
作者 陈聪 侯雅静 +7 位作者 陈云志 刘玥芸 薛哲 吴芊 许梦白 陈家旭 肖飞 裴学军 《世界中医药》 CAS 2019年第9期2251-2253,共3页
小金丹出自清代王维德《外科全生集》,是治疗外科疾病的一个有效方剂,有消岩散结、化瘀祛毒之功。临床应用小金丹治疗某些肿瘤,疗效肯定。研究发现小金丹提取物作用24 h后能明显抑制人乳腺癌MDA-MB-453细胞的运动和侵袭能力,作用呈现剂... 小金丹出自清代王维德《外科全生集》,是治疗外科疾病的一个有效方剂,有消岩散结、化瘀祛毒之功。临床应用小金丹治疗某些肿瘤,疗效肯定。研究发现小金丹提取物作用24 h后能明显抑制人乳腺癌MDA-MB-453细胞的运动和侵袭能力,作用呈现剂量依赖性关系。在消化系统疾病中,加减小金丹对胃癌术后患者高凝、低纤溶、低细胞免疫状态有良好的治疗作用;并推迟转移发生,延长胃癌术后患者生存时间。小金丹可显著影响人肝癌细胞信号转导基因的表达。小金丹联合其他中药,还可治愈胰腺癌。在呼吸系统疾病,特别是肺癌的治疗方面,小金丹观察组有效率高于对照组;对于咯血症状的肺癌,用小金丹以活血通络,化瘀止血,配合西药治疗,可共达止血之效。此外,还发现小金丹可以治疗脑肿瘤、颈部肿块、骨肿瘤、非霍奇金淋巴瘤,疗效肯定。小金丹诸药共用,化瘀、解毒、止痛、行气、散结等功效,将其用于肿瘤的治疗,可以取得较好的临床疗效。 展开更多
关键词 小金丹 消化系统肿瘤 呼吸系统肿瘤 胰腺癌 脑肿瘤 颈部肿块 骨肿瘤 非霍奇金淋巴瘤
下载PDF
口腔肿瘤患者心理压力与体内相关因素变化的初探 被引量:6
11
作者 李博 李黎 +6 位作者 黄一冰 郭黛墨 潘唯一 段泽西 邹晓莉 朱彩蓉 谢蟪旭 《口腔颌面外科杂志》 CAS 2013年第5期369-373,共5页
目的:认识口腔肿瘤患者精神因素变化规律,探索其相关物质基础。方法 :我院2011-12—2012-08间确诊的口腔恶性肿瘤患者40例,良性肿瘤患者35例,应用流行病学调查中心抑郁量表(CES-D)和压力知觉量表(PSS)测评每位受试者抑郁以及心理压力状... 目的:认识口腔肿瘤患者精神因素变化规律,探索其相关物质基础。方法 :我院2011-12—2012-08间确诊的口腔恶性肿瘤患者40例,良性肿瘤患者35例,应用流行病学调查中心抑郁量表(CES-D)和压力知觉量表(PSS)测评每位受试者抑郁以及心理压力状态。于入院次日上午9:00抽取受试者的全血,切取新鲜术后肿瘤组织,分离提取血清,匀浆肿瘤组织,采用高效液相色谱-质谱(HPLC-MS/MS)分析血清中儿茶酚胺以及糖皮质激素含量。结果:口腔恶性肿瘤组CES-D总分得分比口腔良性肿瘤组高,抑郁程度更重,差异有统计学意义(P<0.05)。口腔恶性肿瘤组PSS总分得分与口腔良性肿瘤组之间差异没有统计学意义(P>0.05)。血清中肾上腺素、去甲肾上腺素、氢化可的松及可的松的检测结果,口腔恶性肿瘤组与口腔良性肿瘤组差异有统计学意义(P<0.001);对肿瘤组织的物质分析提示,恶性肿瘤组织中肾上腺素和去甲肾上腺素含量均高于良性肿瘤组织,差异没有统计学意义。结论:口腔肿瘤患者存在明显的精神心理因素变化,同时伴有机体内相关物质变化,影响着恶性肿瘤的发生发展,对进一步研究恶性肿瘤疾病进程的相关机制及探索干预方法有一定价值。 展开更多
关键词 流行病学调查中心抑郁量表 压力知觉量表 口腔肿瘤 高效液相色谱 质谱
下载PDF
粪便标志物检测在大肠癌筛查中的应用 被引量:5
12
作者 张健锋(综述) 毛振彪(审校) 《国际肿瘤学杂志》 CAS 2007年第7期522-525,共4页
大肠癌早期发生中常伴随基因突变、蛋白质和酶等分子代谢异常,通过检测粪便中基因、蛋白质和酶等标志物有助于大肠癌早期诊断。其中粪便K—ras、APC、p53、长片段DNA、DNA甲基化、钙卫蛋白(CPT)、微型染色体维持蛋白一2、促衰变因子... 大肠癌早期发生中常伴随基因突变、蛋白质和酶等分子代谢异常,通过检测粪便中基因、蛋白质和酶等标志物有助于大肠癌早期诊断。其中粪便K—ras、APC、p53、长片段DNA、DNA甲基化、钙卫蛋白(CPT)、微型染色体维持蛋白一2、促衰变因子、癌胚抗原(CEA)、Adnab-9和端粒酶、环氧合酶2(COX-2)、肿瘤M2型丙酮酸激酶(TUM2-PK)等在筛选大肠癌中取得了较大进展。 展开更多
关键词 结直肠肿瘤 肿瘤标记 生物学 粪便 人群筛查
原文传递
多模态超声鉴别非肿块型乳腺原位癌与浸润癌的临床价值 被引量:4
13
作者 谢芸 何佳丽 骆韵青 《临床超声医学杂志》 CSCD 2023年第2期148-152,共5页
目的探讨多模态超声在鉴别非肿块型乳腺原位癌与浸润癌中的临床价值。方法选取我院经手术病理确诊的单侧非肿块型乳腺癌患者52例,共59个病灶,其中原位癌31个,浸润癌28个;应用单因素分析二者常规超声、超声造影、超声弹性成像特征,将单... 目的探讨多模态超声在鉴别非肿块型乳腺原位癌与浸润癌中的临床价值。方法选取我院经手术病理确诊的单侧非肿块型乳腺癌患者52例,共59个病灶,其中原位癌31个,浸润癌28个;应用单因素分析二者常规超声、超声造影、超声弹性成像特征,将单因素分析中差异有统计学意义的超声特征纳入Logistic回归分析筛选相关影响因素,并建立Logistic回归模型。绘制受试者工作特征(ROC)曲线分析Logistic回归模型鉴别非肿块型乳腺原位癌与浸润癌的诊断效能。结果非肿块型乳腺原位癌与浸润癌病灶最大径、方位、形态、后方回声、边缘、淋巴结形态、微钙化、血流分级,造影后有无放射性增强或穿入血管及片状低回声区范围变化、形态、边界、增强水平,以及弹性成像评分比较差异均有统计学意义(均P<0.05)。Logistic回归分析显示,病灶边缘不光整、非平行位、微钙化、血流分级(Ⅱ/Ⅲ级)、造影后片状低回声区范围扩大及放射性增强或穿入血管、弹性成像评分4~5分是鉴别非肿块型乳腺原位癌与浸润癌的影响因素(OR=14.749、3.750、8.849、3.156、8.301、6.467、5.468,均P<0.05)。建立多模态超声诊断模型:Logit(P)=-18.544+边缘不光整×2.691+非平行位×1.321+微钙化×2.185+血流分级(Ⅱ/Ⅲ级)×1.152+造影后放射性增强或穿入血管×1.868+造影后片状低回声区范围扩大×2.118+弹性成像评分(4~5分)×1.698。多模态超声诊断模型鉴别非肿块型乳腺原位癌与浸润癌的灵敏度、特异度、准确率、曲线下面积分别为84.5%、73.5%、86.4%、0.836。结论多模态超声在鉴别非肿块型乳腺原位癌与浸润癌中有一定的临床价值。 展开更多
关键词 超声检查 浸润癌 原位癌 乳腺肿瘤 恶性 非肿块型
下载PDF
Aggressive fibromatosis of the sigmoid colon:A case report
14
作者 Pan-Pan Yu Xin-Chun Liu +1 位作者 Lu Yin Guang Yin 《World Journal of Gastrointestinal Oncology》 SCIE 2024年第8期3716-3722,共7页
BACKGROUND Aggressive fibromatosis(AF),also known as desmoid tumor or desmoid-type fibromatosis,is a rare soft tissue neoplasm that can occur in almost any part of the body.Although it is a benign disease,AF is aggres... BACKGROUND Aggressive fibromatosis(AF),also known as desmoid tumor or desmoid-type fibromatosis,is a rare soft tissue neoplasm that can occur in almost any part of the body.Although it is a benign disease,AF is aggressive and infiltrative and has a high recurrence rate after surgery.Common sites for intra-abdominal AF are the small bowel mesentery,retroperitoneum,and pelvis.AF in the colon is extremely rare.CASE SUMMARY Here,we report the first case of sigmoid colon AF,which was accidentally discovered in a 27-year-old woman during laparoscopic myomectomy.Computed tomography confirmed a slightly enhanced mass in the sigmoid colon.Subsequent colonoscopy did not reveal a mass in the colonic lumen,but a suspected external compress was found in the sigmoid colon.Surgical disease involving a gastrointestinal stromal tumor was suspected.The patient underwent laparoscopic exploration,and sigmoidectomy with a negative margin was performed to excise the mass.Postoperative immunohistochemistry revealed that the mass was an AF.The patient recovered well and was recurrence-free at the 30-month follow-up without adjuvant therapy.CONCLUSION AF should be considered in the differential diagnosis of subepithelial colon masses.Radical resection alone can achieve good outcomes. 展开更多
关键词 Aggressive fibromatosis Desmoid tumor Sigmoid mass Subepithelial tumor Case report
下载PDF
Small cell carcinoma of the liver and biliary tract without jaundice 被引量:2
15
作者 Jae-Min Jo Yoo-Kyung Cho +5 位作者 Chang-Lim Hyun Kyoung-Hee Han Ji-Young Rhee Jung-Mi Kwon Woo-Kun Kim Sang-Hoon Han 《World Journal of Gastroenterology》 SCIE CAS 2013年第44期8146-8150,共5页
An 80-year-old woman presenting with chest pain was found to have a large,lobulated soft tissue mass in the liver and nearby tissues on abdominal computed tomography(CT).The tumor had invaded the common hepatic artery... An 80-year-old woman presenting with chest pain was found to have a large,lobulated soft tissue mass in the liver and nearby tissues on abdominal computed tomography(CT).The tumor had invaded the common hepatic artery and main portal vein.Jaundice developed 4 wk later,at which point,a pancreas and biliary CT scan revealed a large mass in the right lobe of the liver and a hilar duct obstruction,which was found to be a small cell carcinoma.Despite its rarity,liver and bile duct small cell carcinoma should be considered in the differential diagnosis of atypical chest pain without jaundice. 展开更多
关键词 EXTRAPULMONARY small cell carcinoma JAUNDICE LIVER mass BILE duct mass NEUROENDOCRINE tumor
下载PDF
浸润性乳腺癌患者非肿块强化和肿块强化的动态增强MRI特征分析
16
作者 程世德 吴海峰 +2 位作者 钱超鹏 潘鑫 赵红 《医学影像学杂志》 2024年第3期53-56,共4页
目的探讨分析动态增强MRI特征为非肿块强化和肿块强化的浸润性乳腺癌患者影像特征。方法选取浸润性乳腺癌患者55例,行乳腺动态增强MRI检查显示为非肿块强化和肿块强化患者,分别作为观察组和对照组均经手术或病理活检证实,评估两组表观... 目的探讨分析动态增强MRI特征为非肿块强化和肿块强化的浸润性乳腺癌患者影像特征。方法选取浸润性乳腺癌患者55例,行乳腺动态增强MRI检查显示为非肿块强化和肿块强化患者,分别作为观察组和对照组均经手术或病理活检证实,评估两组表观扩散系数(ADC)值、早期强化率、肿块边界清晰、增强平台类型,病灶大小、雌激素受体(ER)、人表皮生长因子受体-2(HER-2)阳性、T分期、N分期结果。结果观察组表观扩散系数(ADC)值为(1.29±0.20)×10^(-3) mm^(2)/s,高于对照组(0.89±0.18)×10^(-3) mm^(2)/s,差异具有统计学意义(P<0.05),观察组肿块边界不清晰发生率为80.52%,高于对照组20.59%,差异具有统计学意义(P<0.05),观察组病灶体积为(25.50±4.21)cm^(3),高于对照组(16.65±3.92)cm^(3),差异具有统计学意义(P<0.05),观察组HER-2阳性率为76.19%,高于对照组26.47%,两组T分期、N分期比较,差异具有统计学意义(P<0.05)。结论对非肿块强化和肿块强化浸润性乳腺癌患者,动态增强MRI通过多参数、多方位成像进行鉴别,非肿块强化病灶ADC值、边界不清晰发生率及ER、HER-2阳性率表现为增高。 展开更多
关键词 浸润性乳腺癌 肿块 非肿块 磁共振成像
下载PDF
Primary Extra-Gastrointestinal Stromal Tumor (GIST) arising from mesentery of small bowel and presenting as abdominal mass: A rare entity 被引量:1
17
作者 Alok Kumar Tiwari Anil Kumar Choudhary +2 位作者 Hemant Khowal Poras Chaudhary Mohinder P. Arora 《Open Journal of Gastroenterology》 2013年第5期267-271,共5页
Introduction: Majority of mesenchymal tumors of gastrointestinal tract are Gastrointestinal Stromal Tumor (GIST). It is, however, a rare tumor, accounting for less than 1% of primary gastrointestinal (GI) neoplasms. T... Introduction: Majority of mesenchymal tumors of gastrointestinal tract are Gastrointestinal Stromal Tumor (GIST). It is, however, a rare tumor, accounting for less than 1% of primary gastrointestinal (GI) neoplasms. Though, these tumors are refractory to conventional chemotherapy or radiotherapy but show a good response to targeted adjuvant chemotherapy with tyrosine kinase inhibitors following surgical resection. Case Report: we report here a case of primary Extra-GIST tumor arising from mesentry of small bowel near duodeno-jejunal junction in a 69 years old male patient. The patient presented with a palpable mass in upper abdomen for past 15 days. On examination, a non-tender mobile lump of size around 17 × 10 cm, with bosselated surface and firm in consistency was palpable involving epigastric, left hypochondrium and umbilical region. Contrast enhanced computed tomography of abdomen revealed a heterogenous mesentric mass. On surgical intervention a mass was found involving mesentery near dudenojejunal junction without involvement of gastrointestinal tract. Complete surgical resection of the tumor was done and adjuvant chemotherapy with Imatinib mesylate was started as HPE revealing GIST with mitotic index of >10/50 HPF and 17 × 10 cm size placed the patient in high risk category. Patient was discharged on 12th of post-operative day with advice of regular follow-up. Conclusion: GIST occurrence is not restricted to bowel but can involve unusual sites also. The mainstay of treatment remains surgical resection with adequate margin. In cases where tumour has malignant potential (high mitotic figures on histopathology) adjuvent treatment with tyrosine kinase may prevent or delay relapse. 展开更多
关键词 Extra-Gastrointestinal Stromal tumorS GIST Mesentric tumorS IMATINIB MESYLATE Abdominal mass
下载PDF
澳洲茄碱对肺癌A549细胞生物活性、瘤体抑制及MAPK/ERK1/2的影响
18
作者 易华 施琳 孙嘉阳 《内蒙古医科大学学报》 2024年第3期231-236,共6页
目的澳洲茄碱对肺癌A549细胞生物活性、瘤体抑制及MAPK/ERK1/2信号的影响。方法将人肺癌细胞株A549分为空白组、低剂量澳洲茄碱组、中剂量澳洲茄碱组、高剂量澳洲茄碱组及顺铂组,分别加入浓度为0、15、20、25μmol/L的澳洲茄碱及2μg/m... 目的澳洲茄碱对肺癌A549细胞生物活性、瘤体抑制及MAPK/ERK1/2信号的影响。方法将人肺癌细胞株A549分为空白组、低剂量澳洲茄碱组、中剂量澳洲茄碱组、高剂量澳洲茄碱组及顺铂组,分别加入浓度为0、15、20、25μmol/L的澳洲茄碱及2μg/mL顺铂培养。MTT检测活性;流式细胞仪检测凋亡率;Transwell法检测侵袭;划痕试验检测划痕愈合率。25只裸鼠分为空白组、低剂量澳洲茄碱组、中剂量澳洲茄碱组、高剂量澳洲茄碱组及顺铂组,皮下注射0.3 mL的0、15、20、25μmol/L的澳洲茄碱及2μg/mL顺铂共培养A549细胞,观察瘤体质量及抑瘤率。结果澳洲茄碱组降低A549细胞活性,凋亡率升高,侵袭、划痕愈合率、MAPK、p-MAPK、ERK1/2及p-ERK1/2蛋白水平降低(P<0.05)。结论澳洲茄碱可抑制肺癌细胞增殖、侵袭及转移,并加快凋亡,作用呈现剂量依赖性且高剂量效果最佳,研究机制可能与抑制MAPK/ERK1/2信号表达相关。 展开更多
关键词 肺癌 澳洲茄碱 瘤体质量 丝裂原活化蛋白激酶 细胞外信号调节激酶
下载PDF
CD45^(+)CD326^(+)双阳性细胞的特征及其在膀胱癌预后预测中的作用
19
作者 刘桧 莫晗 +3 位作者 冯超 谢远亮 王秋雁 李天宇 《中国癌症防治杂志》 CAS 2024年第2期205-214,共10页
目的探讨CD45^(+)CD326^(+)双阳性细胞(double positive cells,DPCs)对膀胱癌预后的影响,并构建膀胱癌DPCs相关基因评分系统,探究不同DPCs评分膀胱癌患者肿瘤微环境的特征。方法采用单细胞测序技术分析DPCs的分子特征,质谱流式技术分析D... 目的探讨CD45^(+)CD326^(+)双阳性细胞(double positive cells,DPCs)对膀胱癌预后的影响,并构建膀胱癌DPCs相关基因评分系统,探究不同DPCs评分膀胱癌患者肿瘤微环境的特征。方法采用单细胞测序技术分析DPCs的分子特征,质谱流式技术分析DPCs高比例组和低比例组患者的肿瘤微环境异质性。基于TCGA‐BLCA队列,根据DPCs的特征基因构建评分系统,并在GSE13507队列及GSE32894队列中进行验证。结果膀胱癌患者中DPCs高比例组患者的预后较低比例组患者的预后差(P=0.0158),且高、低比例组患者的肿瘤微环境存在异质性,高比例组患者较低比例患者的免疫细胞和肿瘤细胞有更高的免疫检查点、共抑制因子和共激活因子的表达水平(均P<0.05);基于TCGA‐BLCA队列构建了9个基因(APOBEC3G、CD96、CLEC2D、GNG2、GNLY、IL32、PSMB9、RORA、SKAP1)的膀胱癌DPCs相关基因评分系统。TCGA‐BLCA队列、GSE13507队列和GSE32894队列分析结果显示,高风险评分组膀胱癌患者的总生存期明显比低DPCs评分组短(均P<0.01)。免疫抑制、雌激素等信号通路在高风险评分组中显著富集。结论DPCs与膀胱癌不良预后密切相关,基于DPCs特征基因构建的模型可较准确地预测膀胱癌患者的临床预后。 展开更多
关键词 膀胱癌 肿瘤微环境 质谱流式技术 单细胞测序技术 免疫抑制
下载PDF
揿针联合桂枝茯苓丸治疗乳腺增生临床研究 被引量:4
20
作者 林奕岑 何丹 《新中医》 CAS 2022年第24期158-161,共4页
目的:观察揿针联合桂枝茯苓丸治疗乳腺增生的临床疗效。方法:选取102例乳腺增生患者,按随机数字表法分为对照组和研究组各51例,其中研究组脱落8例,最终纳入研究43例。对照组给予桂枝茯苓丸治疗,研究组在对照组基础上联合揿针治疗,2组均... 目的:观察揿针联合桂枝茯苓丸治疗乳腺增生的临床疗效。方法:选取102例乳腺增生患者,按随机数字表法分为对照组和研究组各51例,其中研究组脱落8例,最终纳入研究43例。对照组给予桂枝茯苓丸治疗,研究组在对照组基础上联合揿针治疗,2组均治疗3个月经周期。比较2组临床疗效及治疗前后乳房疼痛评分、肿块大小、肿块硬度评分、焦虑自评量表(SAS)评分、抑郁自评量表(SDS)评分和生活质量综合评定问卷(GQOLI)评分。结果:研究总有效率97.67%,高于对照组82.35%(P<0.05)。治疗后,2组乳房疼痛、肿块硬度评分均较治疗前降低(P<0.05),肿块直径均较治疗前缩小(P<0.05);研究组乳房疼痛、肿块硬度评分均低于对照组(P<0.05),肿块直径小于对照组(P<0.05)。治疗后,2组SAS、SDS评分均较治疗前降低(P<0.05),研究组SAS、SDS评分均低于对照组(P<0.05);2组GQOLI各项细则评分及总分均较治疗前升高(P<0.05),研究组GQOLI各项细则评分及总分均高于对照组(P<0.05)。结论:揿针联合桂枝茯苓丸治疗乳腺增生,可有效缓解患者乳房疼痛和负性情绪,缩小乳房肿块,提高其生活质量。 展开更多
关键词 乳腺增生 揿针 桂枝茯苓丸 疼痛 肿块 焦虑 抑郁 生活质量
原文传递
上一页 1 2 9 下一页 到第
使用帮助 返回顶部